ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

INO vs QUCY // 10Y YIELD & FRED MACRO BETA

Inovio Pharmaceuticals Inc. (NASDAQ) VS. Quantum Cyber N.V. (NASDAQ) • 15-METRIC TALLY: INO 1 — QUCY 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INO VS. QUCY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC INO QUCY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 72.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -13.84% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% -39.90% -25.10 QUCY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 QUCY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.1 31.3 -4.27 QUCY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $79.8M $79.4M $432.7K INO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR INO REV QUCY REV INO GROSS % QUCY GROSS % INO FCF QUCY FCF
FY 2025 $65.3K $537.1K — 72.6% -$88.9M -$11.0M
FY 2024 $217.8K $894.0K — 64.3% -$104.6M -$17.4M
FY 2023 $832.0K — — — -$124.4M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INO // BETA —
QUCY // BETA —